Pretreatment serum lactate dehydrogenase is an independent prognostic factor for patients receiving neoadjuvant chemotherapy for locally advanced cervical cancer

about

Prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in cervical cancer: a meta-analysis and systematic review.Identification and validation of the role of matrix metalloproteinase-1 in cervical cancer.

P2860

Q37706629-5879BD34-732A-4D89-8A78-30AE6E53778E Q50047865-B76B65D0-8AC7-403B-8B34-92DA1A219A2F

P2860

Pretreatment serum lactate dehydrogenase is an independent prognostic factor for patients receiving neoadjuvant chemotherapy for locally advanced cervical cancer

Item

http://www.wikidata.org/entity/Q37148936

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 28 June 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Pretreatment serum lactate deh ...... cally advanced cervical cancer

@en

Pretreatment serum lactate deh ...... ally advanced cervical cancer.

@nl

type

Item

label

Pretreatment serum lactate deh ...... cally advanced cervical cancer

@en

Pretreatment serum lactate deh ...... ally advanced cervical cancer.

@nl

prefLabel

Pretreatment serum lactate deh ...... cally advanced cervical cancer

@en

Pretreatment serum lactate deh ...... ally advanced cervical cancer.

@nl

P1476

Pretreatment serum lactate deh ...... cally advanced cervical cancer

@en

P2093

Huai-Wu Lu

http://www.w3.org/2001/XMLSchema#string

Jing Li

http://www.w3.org/2001/XMLSchema#string

Li-Juan Wang

http://www.w3.org/2001/XMLSchema#string

Miao-Fang Wu

http://www.w3.org/2001/XMLSchema#string

Qing Chen

http://www.w3.org/2001/XMLSchema#string

Zhong-Qiu Lin

http://www.w3.org/2001/XMLSchema#string

P2860

Tumour heterogeneity and the evolution of polyclonal drug resistance

On the Origin of Cancer Cells

Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects

Prognostic factors and prognostic staging system for small cell lung cancer

Hypoxia--a key regulatory factor in tumour growth

Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials.

Bortezomib and dexamethasone for multiple myeloma: higher AST and LDH levels associated with a worse prognosis on overall survival

Efficacy of neoadjuvant chemotherapy in patients with FIGO stage IB1 to IIA cervical cancer: an international collaborative meta-analysis.

Novel uterine sarcoma preoperative diagnosis score predicts the need for surgery in patients presenting with a uterine mass.

The predictive value of serum squamous cell carcinoma antigen in patients with cervical cancer who receive neoadjuvant chemotherapy followed by radical surgery: a single-institute study.

P304

1863-1872

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CAM4.779

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27350066

http://www.w3.org/2001/XMLSchema#string

P921

chemotherapy

P932

4971915

http://www.w3.org/2001/XMLSchema#string

Pretreatment serum lactate dehydrogenase is an independent prognostic factor for patients receiving neoadjuvant chemotherapy for locally advanced cervical cancer

about

P2860

P2860

Pretreatment serum lactate dehydrogenase is an independent prognostic factor for patients receiving neoadjuvant chemotherapy for locally advanced cervical cancer

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932